Who are the key players in North America Immuno Oncology Assays Market industry?

The top five key players are Thermo Fisher Scientific, Roche Diagnostics, Agilent Technologies, Illumina, and Bio-Rad Laboratories. These companies offer innovative immuno-oncology platforms and assays, focusing on enhanced biomarker discovery, personalized immunotherapy, and improved cancer diagnostics to solidify their leadership in the North American market.

What is the North America Immuno Oncology Assays Market growth?

The North America Immuno Oncology Assays Market has demonstrated strong growth with a CAGR above 10% in recent years, driven by increased investment in cancer research and new assay launches by companies like Thermo Fisher Scientific. Growing demand for personalized treatment options is further accelerating market expansion.

Which segment accounted for the largest North America Immuno Oncology Assays Market share?

The research applications segment holds the largest market share, as pharmaceutical companies and research institutes focus on developing advanced immunotherapies and biomarker analysis. The rising adoption of immuno-oncology assays in clinical trials and translational research is fueling growth in this application segment across North America.

What are the factors driving the North America Immuno Oncology Assays Market?

Key drivers include increasing cancer incidence, rising demand for precision medicine, and technological advancements in immuno-oncology assays. For example, Roche Diagnostics has introduced next-generation sequencing-based diagnostic kits, enabling better patient stratification and treatment outcomes, which contributes to the overall market growth.

Which type accounted for the largest North America Immuno Oncology Assays Market share?

The PCR (Polymerase Chain Reaction) assays type held the largest market share, owing to its widespread use in genetic profiling, biomarker detection, and minimal residual disease monitoring. PCR-based immuno-oncology assays are popular among laboratories for their high sensitivity, accuracy, and rapid turnaround.

Home Healthcare

North America Immuno Oncology Assays Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Immuno Oncology Assays Market: by Type (Reagents & Kits, Instruments, Software & Services), Application (Research, Clinical Diagnostics, Drug Development, Biomarker Discovery, Companion Diagnostics, Others), Distribution Channels (Direct Tenders, Retail Sales, E-commerce, Wholesalers/Distributors, Hospital Pharmacies, Others), Technology (PCR, Immunoassay, NGS, Flow Cytometry, ELISA, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20391

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	1850
Regions	US, Canada, Mexico
Segments	By Type, By Application, By Distribution Channels, By Technology, By Organization Size
Players	Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Illumina Inc., Agilent Technologies, QIAGEN, Merck KGaA, Abbott Laboratories, PerkinElmer, BD (Becton, Dickinson and Company), Danaher Corporation, GenScript Biotech Corporation, Promega Corporation, Siemens Healthineers, Bio-Techne Corporation

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	1850
Regions	US, Canada, Mexico
Segments	By Type, By Application, By Distribution Channels, By Technology, By Organization Size
Players	Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Illumina Inc., Agilent Technologies, QIAGEN, Merck KGaA, Abbott Laboratories, PerkinElmer, BD (Becton, Dickinson and Company), Danaher Corporation, GenScript Biotech Corporation, Promega Corporation, Siemens Healthineers, Bio-Techne Corporation